Oxybutynin Extended-Release Tablets and Zoladex Implant
Determining the interaction of Oxybutynin Extended-Release Tablets and Zoladex Implant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: oxybutynin
Brand name: Ditropan XL, Anturol, Gelnique, Oxytrol
Synonyms: Oxybutynin
Generic Name: goserelin
Brand name: Zoladex
Synonyms: Goserelin (implant), Goserelin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Oxybutynin Extended-Release Tablets-Zolate
- Oxybutynin Extended-Release Tablets-Zoledronic acid
- Oxybutynin Extended-Release Tablets-Zoledronic Acid (Bone Health)
- Oxybutynin Extended-Release Tablets-Zoledronic Acid (Zometa)
- Oxybutynin Extended-Release Tablets-Zoledronic Acid Injection
- Oxybutynin Extended-Release Tablets-Zoledronic Acid Injection Concentrate
- Zoladex Implant-Oxybutynin Gel
- Zoladex Implant-Oxybutynin Oral Solution
- Zoladex Implant-Oxybutynin Syrup
- Zoladex Implant-Oxybutynin Tablets
- Zoladex Implant-Oxybutynin transdermal
- Zoladex Implant-Oxybutynin Transdermal System